In db/db mice with type 2 diabetes, Cat-S inhibitors or PAR2 inhibitors have been reported to reduce albuminuria and glomerulosclerosis, as well as other organ complications such as diabetic retinopathy (11). The gene discussed is PIMREG; the disease is diabetic retinopathy.